FI961717A0 - Menetelmä oraalisten, kinoloneja sisältävien valmisteiden valmistamiseksi - Google Patents

Menetelmä oraalisten, kinoloneja sisältävien valmisteiden valmistamiseksi

Info

Publication number
FI961717A0
FI961717A0 FI961717A FI961717A FI961717A0 FI 961717 A0 FI961717 A0 FI 961717A0 FI 961717 A FI961717 A FI 961717A FI 961717 A FI961717 A FI 961717A FI 961717 A0 FI961717 A0 FI 961717A0
Authority
FI
Finland
Prior art keywords
preparation
preparations containing
oral preparations
quinolones
containing quinolones
Prior art date
Application number
FI961717A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI961717A (fi
Inventor
Gabriel Gousset
Philippe Riviere
Original Assignee
Rhone Dpc Europ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Dpc Europ filed Critical Rhone Dpc Europ
Publication of FI961717A0 publication Critical patent/FI961717A0/fi
Publication of FI961717A publication Critical patent/FI961717A/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI961717A 1993-10-21 1996-04-19 Menetelmä oraalisten, kinoloneja sisältävien valmisteiden valmistamiseksi FI961717A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9312550A FR2711524B1 (fr) 1993-10-21 1993-10-21 Procédé de préparation de compositions orales contenant des quinolones.
PCT/FR1994/001212 WO1995011023A1 (fr) 1993-10-21 1994-10-19 Procede de preparation de compositions orales contenant des quinolones

Publications (2)

Publication Number Publication Date
FI961717A0 true FI961717A0 (fi) 1996-04-19
FI961717A FI961717A (fi) 1996-04-19

Family

ID=9452072

Family Applications (1)

Application Number Title Priority Date Filing Date
FI961717A FI961717A (fi) 1993-10-21 1996-04-19 Menetelmä oraalisten, kinoloneja sisältävien valmisteiden valmistamiseksi

Country Status (29)

Country Link
US (1) US5840333A (de)
EP (1) EP0724442A1 (de)
AT (1) ATA905894A (de)
AU (1) AU7997094A (de)
BE (1) BE1007326A3 (de)
CA (1) CA2174444A1 (de)
CH (1) CH686555A5 (de)
CO (1) CO4180603A1 (de)
CZ (1) CZ113696A3 (de)
DZ (1) DZ1818A1 (de)
EE (1) EE9600050A (de)
ES (1) ES2126474B1 (de)
FI (1) FI961717A (de)
FR (1) FR2711524B1 (de)
GB (1) GB2297908B (de)
GR (1) GR1002181B (de)
HU (1) HUT74181A (de)
IE (1) IE940838A1 (de)
IT (1) IT1270672B (de)
MA (1) MA23331A1 (de)
NO (1) NO961429L (de)
NZ (1) NZ274874A (de)
OA (1) OA10282A (de)
PL (1) PL314005A1 (de)
SG (1) SG52202A1 (de)
SK (1) SK50596A3 (de)
TN (1) TNSN94110A1 (de)
WO (2) WO1995011023A1 (de)
ZA (1) ZA948175B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1083885B1 (de) * 1998-06-11 2006-12-27 Pharmacia & Upjohn Company LLC Delavirdin tablettenformulierung
US6342598B1 (en) 1998-11-26 2002-01-29 Bracco International B.V. Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
PT1776109E (pt) * 2004-08-13 2009-03-25 Schering Plough Ltd Formulação farmacêutica que compreende um antibiótico, um triazol e um corticosteróide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639458A (en) * 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
JPH01175936A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd 6.8−ジフルオロ−1−(2−フルオロエチル)−1,4−ジヒドロ−7−(4−メチル−1−ピペラジニル)−4−オキソ−3−キノリンカルボン酸を有効成分とする錠剤
US4973470A (en) * 1989-06-26 1990-11-27 Warner-Lambert Company Sustained release pharmaceutical compositions
JPH10175936A (ja) * 1996-12-17 1998-06-30 Kao Corp 新規アミドアミノポリカルボン酸又はその塩、及びそれを含有する洗浄剤組成物

Also Published As

Publication number Publication date
ES2126474B1 (es) 1999-11-16
EE9600050A (et) 1996-10-15
ITMI942130A1 (it) 1996-04-19
GB9608316D0 (en) 1996-06-26
US5840333A (en) 1998-11-24
NZ274874A (en) 1997-10-24
HUT74181A (en) 1996-11-28
WO1995011023A1 (fr) 1995-04-27
FR2711524A1 (fr) 1995-05-05
SG52202A1 (en) 1998-09-28
EP0724442A1 (de) 1996-08-07
CA2174444A1 (fr) 1995-04-27
NO961429D0 (no) 1996-04-11
OA10282A (fr) 1997-10-07
GB2297908B (en) 1997-12-10
CZ113696A3 (en) 1996-07-17
TNSN94110A1 (fr) 1995-09-21
IE940838A1 (en) 1995-05-03
CH686555A5 (fr) 1996-04-30
AU7997094A (en) 1995-05-08
IT1270672B (it) 1997-05-07
DZ1818A1 (fr) 2002-02-17
ATA905894A (de) 2000-06-15
GR1002181B (en) 1996-03-12
PL314005A1 (en) 1996-08-05
WO1995011022A1 (fr) 1995-04-27
BE1007326A3 (fr) 1995-05-16
GB2297908A (en) 1996-08-21
ZA948175B (en) 1995-06-08
NO961429L (no) 1996-04-11
ITMI942130A0 (it) 1994-10-19
CO4180603A1 (es) 1995-06-07
FR2711524B1 (fr) 1995-11-24
SK50596A3 (en) 1997-02-05
ES2126474A1 (es) 1999-03-16
MA23331A1 (fr) 1995-04-01
HU9601041D0 (en) 1996-06-28
FI961717A (fi) 1996-04-19

Similar Documents

Publication Publication Date Title
DE69518331D1 (de) Orale zubereitungen
FI945441A0 (fi) Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmistamiseksi
FI940769A (fi) Menetelmä 2-aminoatsolijohdannaisten valmistamiseksi
FI941447A (fi) Suun kautta annettavat, kapseleina olevat ubidekarenonivalmisteet
FI97951B (fi) Menetelmä kiinteiden oraalisesti käytettävien ifosfamidivalmisteiden valmistamiseksi
NO955082D0 (no) Fremgangsmåte for fremstilling av glutardialdehyd
FI961717A0 (fi) Menetelmä oraalisten, kinoloneja sisältävien valmisteiden valmistamiseksi
NO931839D0 (no) Fremgangsmaate for fremstilling av pergolid
EE9500004A (et) Meetod bensaldehüüdi valmistamiseks
NO930470D0 (no) Framgangsmaate for framstilling av ferrosilisum-legering
FI961178A0 (fi) Menetelmä syklisten cis-1-amino-2-alkanolien valmistamiseksi
NO951350D0 (no) Farmasöytiske preparater inneholdende 3-substituerte 2-oksindol-1-karboksamider
DE68910125D1 (de) Oral-Präparate.
NO972682D0 (no) Ny fremgangsmåte for fremstilling av sameridin
NO924763D0 (no) Ny fremgangsmaate for fremstilling av 4-amino-5-hexensyre
FI940357A (fi) Uusia fluorattuja kinoloneja, menetelmä niiden valmistamiseksi, ja niitä sisältäviä farmaseuttisia valmisteita
FI971964A (fi) Menetelmä 1-halo-3-trialkyylisilasnyylibentseenijohdannaisten valmistamiseksi
FI943660A0 (fi) Menetelmä 3-karbonyyliandrostadieeni-17-karboksamidien valmistamiseksi
ITMI922181A0 (it) Procedimento per la preparazione di perfluoro-2-metil-4-metossipentano
EE02961B1 (et) Isokinoliini derivaadid, neid sisaldavad ravimvormid ja nende saamise protsess
EE9400223A (et) Meetod fenooli valmistamiseks
ITMI930340A0 (it) Procedimento per la preparazione di 5-oxo-2-pirroliconcarbossilato di piridossina
IT8721890A0 (it) Composti amminici stericamente impediti e procedimento per la loro preparazione.
FI955027A (fi) Menetelmä välituotteen valmistamiseksi
ITTO920591A1 (it) Procedimento per la preparazione di n-fosfonometilglicina.